Andrew Edmonds1, Lydia Feinstein, Vitus Okitolonda, Deidre Thompson, Bienvenu Kawende, Frieda Behets. 1. *Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; †Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo; and ‡School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
BACKGROUND: The consequences of decentralizing prevention of mother-to-child HIV transmission and HIV-exposed infant services to antenatal care (ANC)/labor and delivery (L&D) sites from dedicated HIV care and treatment (C&T) centers remain unknown, particularly in low prevalence settings. METHODS: In a cohort of mother-infant pairs, we compared delivery of routine services at ANC/L&D and C&T facilities in Kinshasa, Democratic Republic of Congo from 2010-2013, using methods accounting for competing risks (eg, death). Women could opt to receive interventions at 90 decentralized ANC/L&D sites, or 2 affiliated C&T centers. Additionally, we assessed decentralization's population-level impacts by comparing proportions of women and infants receiving interventions before (2009-2010) and after (2011-2013) decentralization. RESULTS: Among newly HIV-diagnosed women (N = 1482), the 14-week cumulative incidence of receiving the package of CD4 testing and zidovudine or antiretroviral therapy was less at ANC/L&D [66%; 95% confidence interval (CI): 63% to 69%] than at C&T (88%; 95% CI: 83% to 92%) sites (subdistribution hazard ratio, 0.62; 95% CI: 0.55 to 0.69). Delivery of cotrimoxazole and DNA polymerase chain reaction testing to HIV-exposed infants (N = 1182) was inferior at ANC/L&D sites (subdistribution hazard ratio, 0.84; 95% CI: 0.76 to 0.92); the 10-month cumulative incidence of the package at ANC/L&D sites was 89% (95% CI: 82% to 93%) versus 97% (95% CI: 93% to 99%) at C&T centers. Receipt of the pregnancy (20% of 1518, to 64% of 1405) and infant (16%-31%) packages improved post decentralization. CONCLUSIONS: Services were delivered less efficiently at ANC/L&D sites than C&T centers. Although access improved with decentralization, its potential cannot be realized without sufficient and sustained support.
BACKGROUND: The consequences of decentralizing prevention of mother-to-child HIV transmission and HIV-exposed infant services to antenatal care (ANC)/labor and delivery (L&D) sites from dedicated HIV care and treatment (C&T) centers remain unknown, particularly in low prevalence settings. METHODS: In a cohort of mother-infant pairs, we compared delivery of routine services at ANC/L&D and C&T facilities in Kinshasa, Democratic Republic of Congo from 2010-2013, using methods accounting for competing risks (eg, death). Women could opt to receive interventions at 90 decentralized ANC/L&D sites, or 2 affiliated C&T centers. Additionally, we assessed decentralization's population-level impacts by comparing proportions of women and infants receiving interventions before (2009-2010) and after (2011-2013) decentralization. RESULTS: Among newly HIV-diagnosed women (N = 1482), the 14-week cumulative incidence of receiving the package of CD4 testing and zidovudine or antiretroviral therapy was less at ANC/L&D [66%; 95% confidence interval (CI): 63% to 69%] than at C&T (88%; 95% CI: 83% to 92%) sites (subdistribution hazard ratio, 0.62; 95% CI: 0.55 to 0.69). Delivery of cotrimoxazole and DNA polymerase chain reaction testing to HIV-exposed infants (N = 1182) was inferior at ANC/L&D sites (subdistribution hazard ratio, 0.84; 95% CI: 0.76 to 0.92); the 10-month cumulative incidence of the package at ANC/L&D sites was 89% (95% CI: 82% to 93%) versus 97% (95% CI: 93% to 99%) at C&T centers. Receipt of the pregnancy (20% of 1518, to 64% of 1405) and infant (16%-31%) packages improved post decentralization. CONCLUSIONS: Services were delivered less efficiently at ANC/L&D sites than C&T centers. Although access improved with decentralization, its potential cannot be realized without sufficient and sustained support.
Authors: Frieda Mtf Behets; Richard Matendo; Lara Me Vaz; Nick Kilese; Diderot Nanlele; Jack Kokolomami; Emile W Okitolando; Annelies Van Rie Journal: Bull World Health Organ Date: 2006-12 Impact factor: 9.408
Authors: Karin van der Merwe; Matthew F Chersich; Karl Technau; Yvonne Umurungi; Francesca Conradie; Ashraf Coovadia Journal: J Acquir Immune Defic Syndr Date: 2006-12-15 Impact factor: 3.731
Authors: Lisa J Nelson; Michael Beusenberg; Vincent Habiyambere; Nathan Shaffer; Marco A Vitoria; Raul Gonzalez Montero; Philippa J Easterbrook; Meg C Doherty Journal: AIDS Date: 2014-03 Impact factor: 4.177
Authors: Brianna L Smith; Sara Zizzo; Anouk Amzel; Sarah Wiant; Molly C Pezzulo; Sarah Konopka; Rachel Golin; Alexandra C Vrazo Journal: Int J MCH AIDS Date: 2018
Authors: Andrew Edmonds; Ellen Brazier; Beverly S Musick; Marcel Yotebieng; John Humphrey; Lisa L Abuogi; Adebola Adedimeji; Olivia Keiser; Malango Msukwa; James G Carlucci; Marcelle Maia; Jorge A Pinto; Valériane Leroy; Mary-Ann Davies; Kara K Wools-Kaloustian Journal: PLoS Med Date: 2022-09-15 Impact factor: 11.613